Patent details

Basic Information

Publication number:

EP1220611

PCT Application Number:

PCT/US/2000/028011

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP009720632

PCT Publication Number:

WO/2001/026470

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SUPPRESSOR CELLS FOR PREVENTION AND TREATMENT OF IMMUNE RESPONSES IN TRANSPLANTATION

French Title of Invention:

CELLULES SUPRESSIVES DESTINEES AU TRAITEMENT ET A LA PREVENTION DES REPONSES IMMUNITAIRES EN TRANSPLANTATION

German Title of Invention:

SUPPRESSORZELLEN ZUR PRÄVENTION UND BEHANDLUNG VON IMMUNANTWORTEN BEI TRANSPLANTATIONEN

SPC Number:

Dates

Filing date:

10/10/2000

Grant date:

08/03/2006

EP Publication Date:

08/03/2006

PCT Publication Date:

19/04/2001

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/07/2002

EP B1 Publication Date:

08/03/2006

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

10/10/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/06/2018

 

 

Name:

Mesoblast International Sàrl

Address:

Route de Pré-Bois 20, 1217 Meyrin, Switzerland (CH)

History of Owners

From:

06/06/2018

To:

06/06/2018

Name:

Osiris Therapeutics, Inc.

Address:

7015 Albert Einstein Drive, Columbia, MD 21046, United States (US)

From:

10/10/2000

To:

06/06/2018

Name:

Osiris Therapeutics Inc.

Address:

2001 Aliceanna Street, Baltimore, MD 21231-2001, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

24/05/2006

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

MCINTOSH Kevin

Address:

United States (US)

2

Name:

KLUSHNENKOVA Elena

Address:

United States (US)

Priority

Priority Number:

415627

Priority Date:

12/10/1999

Priority Country:

United States (US)

Classification

Main IPC Class:

A01N 63/00;

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2018/08

Publication date:

06/07/2018

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

CO

Bulletin edition number:

2018/08

Publication date:

06/07/2018

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20180000210A

Date Registered:

06/06/2018

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Changement d'adresse

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Osiris Therapeutics, Inc.

Address:

7015 Albert Einstein Drive, Columbia, MD 21046, United States (US)

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20180000212A

Date Registered:

06/06/2018

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Mesoblast International Sàrl

Address:

Route de Pré-Bois 20, 1217 Meyrin, Switzerland (CH)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

24/09/2019

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
06/06/2018	Request For Change	4
07/06/2018	Outgoing Correspondence	1